Keyword search

Sort Help
entries

Results

All (28)

All (28) (0 to 10 of 28 results)

  • Articles and reports: 41-20-00022024003
    Description: The paper presents analysis using data from the Survey on Access to Health Care and Pharmaceuticals during the Pandemic (SAHCPDP) to examine prevalence of prescription insurance, the impact of the pandemic on prescription insurance coverage, medication use, the relationship between appointment scheduling issues and inability to obtain new prescriptions, out-of-pocket medication spending, and the relationship between prescription insurance coverage and medication non-adherence due to cost among First Nations people living off reserve, Métis and Inuit in the provinces.
    Release date: 2024-10-15

  • Articles and reports: 75-006-X202400100001
    Description: Using data from the Canadian Community Health Survey, this study examines men’s and women’s coverage for four types of drug insurance plans (government-sponsored, employer-sponsored, association-sponsored and private drug insurance plans), disaggregated by various socioeconomic, demographic and geographical factors. The study further examines the extent of cost-related medication non-adherence among men and women, disaggregated by type of drug insurance plan.
    Release date: 2024-01-10

  • Articles and reports: 75-006-X202200100011
    Description: This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.
    Release date: 2022-11-02

  • Stats in brief: 11-627-M2022071
    Description: Based on data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, this infographic examines pharmaceutical access and use across regions and immigration status. It also looks out-of-pocket spending on medication and non-adherence to prescription medication because of cost.
    Release date: 2022-11-02

  • Articles and reports: 82-003-X202200700001
    Description:

    There has been increasing scrutiny of opioid prescribing following injury given concerns that prescribed opioids may contribute to addiction and/or overdose. This study aimed to better understand the relationship between injury, opioids prescribed pre- and post-injury, and non-medical drug poisoning. Focusing on working age (15-65 years old) residents of the Fraser Health region, this study used a linked administrative dataset to better understand the relationships between injury, whether the injury was work-related or sustained outside of the workplace, pain management medication in the form of opioid and opioid agonist therapy prescriptions before and after injury, and potential non-medical drug poisoning.

    Release date: 2022-07-20

  • Articles and reports: 82-003-X202200600001
    Description:

    Estimates of polypharmacy (the concurrent use of five-or-more medications) have primarily been derived from prescription claims. Less is known about the use of non-prescription medications (alone or in combination with prescription medications) across the frailty spectrum or by sex. This study estimates the prevalence of polypharmacy (total, prescription, non-prescription, and concurrent prescription/non-prescription) overall, and by frailty, sex, and broad age groups.

    Release date: 2022-06-15

  • Articles and reports: 82-003-X202101200002
    Description:

    Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

    Release date: 2022-01-19

  • Stats in brief: 11-627-M2021060
    Description:

    The opioid epidemic continues to have deadly consequences for thousands of Canadians each year. This infographic uses data from a pilot study led by Statistics Canada that created a linked cohort of people experiencing overdoses in Simcoe Muskoka between January 1, 2018 and December 31, 2019. It provides a profile of those who experienced an overdose and looks at how they interact with the different systems.

    Release date: 2021-07-15

  • Articles and reports: 82-003-X202100300001
    Description:

    Prescription medications are used throughout the life course, including among children and youth. This article describes prescription medication use in the past month among those aged 3 to 19 years.

    Release date: 2021-03-17

  • Articles and reports: 11-633-X2021003
    Description:

    Canada continues to experience an opioid crisis. While there is solid information on the demographic and geographic characteristics of people experiencing fatal and non-fatal opioid overdoses in Canada, there is limited information on the social and economic conditions of those who experience these events. To fill this information gap, Statistics Canada collaborated with existing partnerships in British Columbia, including the BC Coroners Service, BC Stats, the BC Centre for Disease Control and the British Columbia Ministry of Health, to create the Statistics Canada British Columbia Opioid Overdose Analytical File (BC-OOAF).

    Release date: 2021-02-17
Data (1)

Data (1) ((1 result))

  • Table: 62-010-X
    Description:

    The publication highlights current and historical statistics on consumer prices and related price indexes. A comparative index contains retail price differentials for 11 major cities by selected groups of consumer goods and services.

    Release date: 1999-08-03
Analysis (26)

Analysis (26) (0 to 10 of 26 results)

  • Articles and reports: 41-20-00022024003
    Description: The paper presents analysis using data from the Survey on Access to Health Care and Pharmaceuticals during the Pandemic (SAHCPDP) to examine prevalence of prescription insurance, the impact of the pandemic on prescription insurance coverage, medication use, the relationship between appointment scheduling issues and inability to obtain new prescriptions, out-of-pocket medication spending, and the relationship between prescription insurance coverage and medication non-adherence due to cost among First Nations people living off reserve, Métis and Inuit in the provinces.
    Release date: 2024-10-15

  • Articles and reports: 75-006-X202400100001
    Description: Using data from the Canadian Community Health Survey, this study examines men’s and women’s coverage for four types of drug insurance plans (government-sponsored, employer-sponsored, association-sponsored and private drug insurance plans), disaggregated by various socioeconomic, demographic and geographical factors. The study further examines the extent of cost-related medication non-adherence among men and women, disaggregated by type of drug insurance plan.
    Release date: 2024-01-10

  • Articles and reports: 75-006-X202200100011
    Description: This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.
    Release date: 2022-11-02

  • Stats in brief: 11-627-M2022071
    Description: Based on data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, this infographic examines pharmaceutical access and use across regions and immigration status. It also looks out-of-pocket spending on medication and non-adherence to prescription medication because of cost.
    Release date: 2022-11-02

  • Articles and reports: 82-003-X202200700001
    Description:

    There has been increasing scrutiny of opioid prescribing following injury given concerns that prescribed opioids may contribute to addiction and/or overdose. This study aimed to better understand the relationship between injury, opioids prescribed pre- and post-injury, and non-medical drug poisoning. Focusing on working age (15-65 years old) residents of the Fraser Health region, this study used a linked administrative dataset to better understand the relationships between injury, whether the injury was work-related or sustained outside of the workplace, pain management medication in the form of opioid and opioid agonist therapy prescriptions before and after injury, and potential non-medical drug poisoning.

    Release date: 2022-07-20

  • Articles and reports: 82-003-X202200600001
    Description:

    Estimates of polypharmacy (the concurrent use of five-or-more medications) have primarily been derived from prescription claims. Less is known about the use of non-prescription medications (alone or in combination with prescription medications) across the frailty spectrum or by sex. This study estimates the prevalence of polypharmacy (total, prescription, non-prescription, and concurrent prescription/non-prescription) overall, and by frailty, sex, and broad age groups.

    Release date: 2022-06-15

  • Articles and reports: 82-003-X202101200002
    Description:

    Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

    Release date: 2022-01-19

  • Stats in brief: 11-627-M2021060
    Description:

    The opioid epidemic continues to have deadly consequences for thousands of Canadians each year. This infographic uses data from a pilot study led by Statistics Canada that created a linked cohort of people experiencing overdoses in Simcoe Muskoka between January 1, 2018 and December 31, 2019. It provides a profile of those who experienced an overdose and looks at how they interact with the different systems.

    Release date: 2021-07-15

  • Articles and reports: 82-003-X202100300001
    Description:

    Prescription medications are used throughout the life course, including among children and youth. This article describes prescription medication use in the past month among those aged 3 to 19 years.

    Release date: 2021-03-17

  • Articles and reports: 11-633-X2021003
    Description:

    Canada continues to experience an opioid crisis. While there is solid information on the demographic and geographic characteristics of people experiencing fatal and non-fatal opioid overdoses in Canada, there is limited information on the social and economic conditions of those who experience these events. To fill this information gap, Statistics Canada collaborated with existing partnerships in British Columbia, including the BC Coroners Service, BC Stats, the BC Centre for Disease Control and the British Columbia Ministry of Health, to create the Statistics Canada British Columbia Opioid Overdose Analytical File (BC-OOAF).

    Release date: 2021-02-17
Reference (1)

Reference (1) ((1 result))

  • Surveys and statistical programs – Documentation: 62F0026M2002002
    Geography: Province or territory
    Description:

    This guide presents information of interest to users of data from the Survey of Household Spending. Data are collected via paper questionnaires and personal interviews conducted in January, February and March after the reference year. Information is gathered about the spending habits, dwelling characteristics and household equipment of Canadian households during the reference year. The survey covers private households in the 10 provinces and the 3 territories. (The territories are surveyed every second year, starting in 2001.) This guide includes definitions of survey terms and variables, as well as descriptions of survey methodology and data quality. There is also a section describing the various statistics that can be created using expenditure data (e.g., budget share, market share and aggregates).

    Release date: 2002-12-11
Date modified: